<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 16-year-old male with severe <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and progressive multiple organ infarctions was diagnosed as having catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (CAPS) complicated with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, and was successfully treated with combination of <z:chebi fb="2" ids="50249">anticoagulants</z:chebi>, <z:chebi fb="0" ids="50858">corticosteroids</z:chebi>, plasma exchange, and intravenous <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Antibodies to phosphatidylserine/prothrombin (PS/PT) complex and <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> (CL)/β(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (β(2)GPI) were simultaneously detected, indicating that the different pathways of both PS/PT and CL/β(2)GPI might be associated with the radical manifestation of CAPS </plain></SENT>
</text></document>